Oral News and Research

RSS

Prestige Brands agrees to acquire Blacksmith Brands stock for $190 million

Prestige Brands Holdings, Inc., a leading marketer of branded consumer products, today announced that it has entered into a definitive agreement to acquire 100% of the stock of Blacksmith Brands Holdings, Inc., for $190 million in cash.

20 Sep 2010

Insurers say new health benefits will raise premiums

Starting next week, your insurance company can no longer put dollar limits on essential benefits such as hospital and lab services. Dependent children will be covered to age 26. You'll get preventive care with no deductible or co-pay. But there's a price some insurers are saying they will have to raise premium prices, CBS News reports.

20 Sep 2010

Immunotherapy accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Immunotherapy (ISSN 1750-743X) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

19 Sep 2010

Anthem Blue Cross hosts Hmong Health Awareness Fair with local health and community agencies

Tomorrow, Anthem Blue Cross State Sponsored Business will team with local health and community agencies to host the Hmong Health Awareness Fair. Local health and community organizations will be on hand to provide local families free health screenings, vaccines and health information. The health fair will take place from 9:00 a.m. to 3: p.m. at the Asian Village Shopping Center located at 4903 E. Kings Canyon Road.

18 Sep 2010

HHS Secretary Sebelius announces $130.8 million in grants to expand health professions workforce

HHS Secretary Kathleen Sebelius today announced $130.8 million in grants to strengthen and expand the health professions workforce. Six areas are targeted: primary care workforce training, oral health workforce training, equipment to enhance training across the health professions, loan repayments for health professionals, health careers opportunity programs for disadvantaged students, and patient navigator outreach and chronic disease prevention in health disparity populations.

18 Sep 2010

HRA Pharma, Watson enter licensing agreement for ulipristal acetate emergency contraceptive commercialization

HRA Pharma, a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc. announced today that they have entered into a licensing agreement for the commercialization of HRA Pharma's next generation emergency contraceptive ulipristal acetate in Canada.

18 Sep 2010

Judge releases schedule for health overhaul lawsuit proceedings; Poll finds voters indifferent to candidates' reform positions

The federal judge overseeing a lawsuit brought by 20 states against health reform released a schedule this week that lays out how the case will proceed, The Hill's Healthwatch Blog reports.

18 Sep 2010

Emisphere’s SNAC drug successful in reducing food intake; increasing satiety

Emisphere Technologies, Inc. today announced that a clinical study found that the company's proprietary oral SNAC (Sodium N-[8-(2-hydroxybenzoyl) Amino] Caprylate ("SNAC") additive, in combination with two digestive hormones, was successful in reducing food intake and increasing satiety in healthy male subjects.

18 Sep 2010

Use of oral medications for diabetes increases among Americans: Report

The proportion of Americans reporting treatment for diabetes who took oral medications to treat their condition increased from 60 percent in 1997 to 77 percent in 2007, a 28 percent increase according to the latest News and Numbers from the Agency for Healthcare Research and Quality. During the same period, the proportion taking insulin to control their diabetes fell from 38 percent to 24 percent.

18 Sep 2010

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.

18 Sep 2010

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29, the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain.

18 Sep 2010

First Edition: September 17, 2010

"In a reflection of the battered economy, the number of people without health insurance rose sharply last year to 50.7 million — an all time high — according to data released Thursday by the Census Bureau" (Kaiser Health News). KHN also provides related resources, including a Census Bureau summary of key findings, the chapter on health insurance coverage and access the full report, "Income, Poverty, and Health Insurance Coverage in the United States: 2009."

17 Sep 2010

World Vision reports on healthcare resources

Global efforts to tackle millions of preventable child and maternal deaths will fail to extend gains unless world leaders act now to pour more healthcare resources directly into families and communities, according to a new World Vision report launched today.

17 Sep 2010

Inspire Pharmaceuticals to present denufosol tetrasodium therapy data at ERS Annual Congress

Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.

17 Sep 2010

Fred Hutchinson Cancer Center research team wins 2010 BioFlux Innovation Award

Fluxion Biosciences, Inc. announced today that a research team from Fred Hutchinson Cancer Center has won the 2010 BioFlux Innovation Award competition. Laura Sycuro, Ph.D., a post-doctoral research fellow in the lab of David Fredricks, M.D., authored the winning submission which focuses on screening and characterizing bacterial strains involved in biofilm-related infections known to affect women's reproductive health.

From Fluxion Biosciences 17 Sep 2010

Alcohol addiction drug may help opioid addicts: FDA panel considers reports

A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.

17 Sep 2010

Retina Implant AG presents clinical data of successful subretinal electronic implants

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.

16 Sep 2010

Survey reveals physicians’ misperception on misuse, abuse of opioids

Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.

16 Sep 2010

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.

16 Sep 2010

Advanced Life Sciences participates as exhibitor in 50th ICAAC

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today participated in the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy

16 Sep 2010

Oral News and Research

Prestige Brands agrees to acquire Blacksmith Brands stock for $190 million

Insurers say new health benefits will raise premiums

Immunotherapy accepted for coverage in MEDLINE®

Anthem Blue Cross hosts Hmong Health Awareness Fair with local health and community agencies

HHS Secretary Sebelius announces $130.8 million in grants to expand health professions workforce

HRA Pharma, Watson enter licensing agreement for ulipristal acetate emergency contraceptive commercialization

Judge releases schedule for health overhaul lawsuit proceedings; Poll finds voters indifferent to candidates' reform positions

Emisphere’s SNAC drug successful in reducing food intake; increasing satiety

Use of oral medications for diabetes increases among Americans: Report

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

First Edition: September 17, 2010

World Vision reports on healthcare resources

Inspire Pharmaceuticals to present denufosol tetrasodium therapy data at ERS Annual Congress

Fred Hutchinson Cancer Center research team wins 2010 BioFlux Innovation Award

Alcohol addiction drug may help opioid addicts: FDA panel considers reports

Retina Implant AG presents clinical data of successful subretinal electronic implants

Survey reveals physicians’ misperception on misuse, abuse of opioids

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Advanced Life Sciences participates as exhibitor in 50th ICAAC

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News